Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Selvita is an international preclinical Contract Research Organization (CRO) providing integrated drug discovery and development services. They partner with pharmaceutical and biotechnology companies globally, offering expertise in chemistry, biology, DMPK, in vivo pharmacology, toxicology, and analytical testing to advance therapeutic candidates from concept to clinical trials. Selvita aims to accelerate the R&D process for its clients by delivering high-quality scientific solutions and leveraging its state-of-the-art laboratories and experienced scientific teams.
Serves as the main operational hub, housing advanced research laboratories for drug discovery and development, corporate management, and global client relations.
State-of-the-art laboratory facilities equipped with modern instrumentation, located in a prominent Life Science Park fostering innovation and collaboration.
A dynamic, science-driven environment emphasizing collaboration, innovation, and continuous learning. Fosters an international atmosphere with a focus on delivering high-quality research outcomes.
Strategic location in Central Europe with access to a highly skilled scientific talent pool. It's the core of Selvita's research capabilities and global operations.
Selvita serves a global clientele, primarily pharmaceutical and biotechnology companies across North America, Europe, and Asia. Its core laboratory operations are strategically located in Poland (Krakow, Poznan) and Croatia (Zagreb), offering state-of-the-art research facilities. To support its international clients and foster collaborations, Selvita maintains business development offices in key biotech hubs: Cambridge (MA, USA), South San Francisco (CA, USA), and Cambridge (UK). This network enables Selvita to provide localized support and project management while delivering integrated drug discovery and development services worldwide.
ul. Bobrzyńskiego 14
Krakow
Malopolskie (Lesser Poland)
Poland
Address: ul. Złotniki, Przemysłowa 12, 62-002 Suchy Las
Expansion of Selvita's research capacity and access to scientific talent in western Poland, enhancing their integrated service offerings.
Address: Prilaz baruna Filipovića 29, 10000 Zagreb
Strengthens Selvita's capabilities in later-stage preclinical development and expands its footprint in Southeastern Europe.
Address: One Broadway, 14th Floor, Cambridge, MA 02142
Facilitating direct engagement with pharmaceutical and biotech companies in the Boston/Cambridge innovation ecosystem.
Address: 701 Gateway Boulevard, Suite 250, South San Francisco, CA 94080
Providing local contact and support for clients in another key U.S. biopharmaceutical cluster.
Address: St John’s Innovation Centre, Cowley Road, Cambridge, CB4 0WS
Engaging with the vibrant UK and European life sciences community from a strategic location.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Selvita' leadership includes:
Selvita has been backed by several prominent investors over the years, including:
Selvita has recently focused on strengthening its scientific leadership and board composition. Key appointments include a new Chief Scientific Officer for Drug Development, indicating continued investment in expanding its service portfolio and expertise.
Discover the tools Selvita uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Selvita primarily uses the [firstname].[lastname]@selvita.com email format. This is a common structure for professional communication within the company.
firstname.lastname@selvita.com
Format
john.doe@selvita.com
Example
85%
Success rate
Selvita Investor Relations • May 14, 2024
Selvita announced its financial results for the first quarter of 2024, reporting revenues of PLN 91.8 million and an adjusted EBITDA of PLN 16.7 million. The company highlighted growth in its drug discovery segment and a strong backlog of orders....more
Selvita News • April 23, 2024
Selvita announced its participation in the BioTrinity 2024 conference in London, a leading event for life sciences investment and partnering. This underscores Selvita's commitment to engaging with the European biotech ecosystem....more
Selvita Investor Relations • February 21, 2024
Selvita announced the appointment of Dr. Adrijana Vinter as a Member of the Management Board and Chief Scientific Officer responsible for Drug Development, effective February 21, 2024. This strengthens the company's leadership in preclinical development services....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Selvita, are just a search away.